Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
30.84
-0.09 (-0.29%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Avidity Biosciences Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$68.25
Upside
+121.30%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +94.55% | Apr 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +133.46% | Mar 18, 2025 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +94.55% | Mar 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +133.46% | Mar 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $65 | Strong Buy | Maintains | $65 | +110.77% | Mar 17, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +126.98% | Mar 13, 2025 |
| BMO Capital | BMO Capital | Buy Initiates $72 | Buy | Initiates | $72 | +133.46% | Mar 12, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $51 → $48 | Strong Buy | Maintains | $51 → $48 | +55.64% | Mar 10, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $70 | Buy | Initiates | $70 | +126.98% | Mar 7, 2025 |
| Barclays | Barclays | Buy Maintains $63 → $57 | Buy | Maintains | $63 → $57 | +84.82% | Feb 28, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $65 | Strong Buy | Maintains | $65 | +110.77% | Feb 28, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $67 | Buy | Reiterates | $67 | +117.25% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +133.46% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +133.46% | Dec 20, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $67 | Buy | Initiates | $67 | +117.25% | Nov 26, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $65 | Strong Buy | Maintains | $65 | +110.77% | Nov 13, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.